New York-based MetLife, Inc. (MET) is a financial services company that provides insurance, annuities, employee benefits, and asset management services worldwide. With a market cap of $52.2 billion, the company operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings.

MET is poised to report its fiscal 2025 Q2 earnings on Wednesday, August 6, after the market closes. Ahead of this event, analysts expect the company to report a profit of $2.21 per share, down 3.1% from $2.28 per share in the year-ago quarter. The company has surpassed the Street’s bottom-line projections in one of the past four quarters, while missing on three other occasions.

For fiscal 2025, analysts expect MET to report a profit of $8.96, up 10.5% from $8.11 in fiscal 2024. Furthermore, its EPS is expected to grow 14.3% year over year to $10.24 in fiscal 2026. 

MET stock has grown 7.3% over the past 52 weeks, underperforming the Financial Select Sector SPDR Fund’s (XLF) 23.5% surge and the S&P 500 Index’s ($SPX) 12.1% uptick during the same time frame.

MET stock declined 1.4% following the release of its Q1 results on Apr. 30. The company’s overall adjusted revenues for the quarter increased 10.6% year over year to $18.8 billion, beating the Street’s expectations. Its adjusted EPS for the quarter rose 7.1% from the prior year’s quarter to $1.96, but failed to touch the consensus estimates by 1.5%.

Wall Street analysts are highly bullish about MET’s stock, with a "Strong Buy" rating overall. Among 17 analysts covering the stock, 12 recommend "Strong Buy," one suggests a “Moderate Buy,” and four recommend a “Hold.” MET’s average analyst price target of $95.73 indicates a potential upside of 23.2% from the current levels.